seed
Stage
2020
Founded
2
Investors
About
Anthology is a biotech startup that accelerates biomanufacturing by speeding up genetic mutation and selection processes. The company uses proprietary hardware and digital tools to generate and screen vast genetic variants, aiming to identify improved microbial strains for producing valuable biomolecules.
Explore Anthology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.